The Defense Biotechnology Strategy Act requires the Secretary of Defense to create a comprehensive plan within one year on how biotechnology affects national security and defense. This is about making sure the military can take advantage of new biological science and engineering breakthroughs—things like using biotech to manufacture medical supplies, create new materials, or develop other defense-related products.

The strategy needs to cover several practical areas: how the military can work with private companies to build facilities that produce biotech products for defense purposes, updating military standards to use biotech-based alternatives instead of traditional materials, and making agreements to purchase biotech products in advance. It also includes plans to test these biotechnology applications through military exercises and simulations to see how they'd work in real scenarios.

The bill also asks the Defense Department to consider funding research challenges to make biotechnology more predictable and easier to engineer, develop better regulatory tools and measurement systems for biotech products, and work with NATO allies to coordinate purchasing power and share research capabilities. Essentially, this bill is about making sure the U.S. military stays ahead of the curve in using cutting-edge biotechnology and coordinates with allies to do the same.